(Q81099003)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805312%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805312%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805312%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Charles H Large

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805312%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Adam Schwarz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805312%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Simone Bertani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805312%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Valerio Crestan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805312%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Angelo Bifone

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805312%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

5 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805312%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805312%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805312%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805312%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

1690-1703

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17805312%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301547

5 January 2020

exact match

0 references

cites work

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

MR contrast due to intravascular magnetic susceptibility perturbations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Distinct properties of presynaptic group II and III metabotropic glutamate receptor-mediated inhibition of perforant pathway-CA1 EPSCs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Neurotransmitter interactions in schizophrenia--therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Regulation of neurotransmitter release by metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Ketamine effects on local cerebral blood flow and metabolism in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Cortical serotonin7, 1D and 1F receptors: effects of schizophrenia, suicide and antipsychotic drug treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

The NMDA receptor hypofunction model of psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Analysis of functional MRI time-series

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

A multimodality investigation of cerebral hemodynamics and autoregulation in pharmacological MRI.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Region-specific effects of nicotine on brain activity: a pharmacological MRI study in the drug-naïve rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

RARE imaging: A fast imaging method for clinical MR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Activation of medial prefrontal cortex by phencyclidine is mediated via a hippocampo-prefrontal pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Presynaptic inhibitory action of the group II metabotropic glutamate receptor agonists, LY354740 and DCG-IV.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Functional brain imaging of symptoms and cognition in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

NMDA receptors and schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Interactive effects of subanesthetic ketamine and haloperidol in healthy humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Effects of ketamine in normal and schizophrenic volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

The potential role of lamotrigine in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Mapping the central effects of ketamine in the rat using pharmacological MRI.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Using the BOLD MR signal to differentiate the stereoisomers of ketamine in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Localisation of phencyclidine-induced changes in brain energy metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

1 reference

7 January 2021

N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Volume of the cingulate and outcome in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

PCP: from pharmacology to modelling schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Effects of phencyclidine on immediate early gene expression in the brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Differential amygdala activation in schizophrenia during sadness.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Preclinical pharmacology of mGlu2/3 receptor agonists: novel agents for schizophrenia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: application to pharmacological MRI.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Functional MRI using intravascular contrast agents: detrending of the relative cerebrovascular (rCBV) time course

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Study-level wavelet cluster analysis and data-driven signal models in pharmacological MRI.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Dendritic glutamate-induced bursting in the prefrontal cortex: further characterization and effects of phencyclidine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Testing models of thalamic dysfunction in schizophrenia using neuroimaging.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Metabotropic glutamate receptors as novel targets for anxiety and stress disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Evaluating glutamatergic transmission in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Comparative efficacy of antipsychotics in the treatment of schizophrenia: a critical assessment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Alterations in local cerebral glucose utilization induced by phencyclidine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Wavelet-based cluster analysis: data-driven grouping of voxel time courses with application to perfusion-weighted and pharmacological MRI of the rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

A three-dimensional statistical analysis for CBF activation studies in human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Effects of haloperidol and clozapine on glutamate release from nerve terminals isolated from rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021

Glycine transporters are differentially expressed among CNS cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301547

7 January 2021